Related Experiment Videos

[Clinical aspects of dilated cardiomyopathy in pediatric age]

P Caso1, C Cioppa, B Musto

  • 1Divisione di Cardiologia, Ospedale V Monaldi, USL 41, Napoli.

Cardiologia (Rome, Italy)
|October 1, 1990
PubMed

Insights

Dilated cardiomyopathy in children has unpredictable outcomes. Reduced fractional shortening is a key indicator of poor prognosis, aiding in identifying children who may benefit from cardiac transplant.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research

Background:

  • The natural history and prognostic factors of pediatric dilated cardiomyopathy are poorly understood.
  • Disease progression varies significantly, with some children improving, some remaining stable, and others rapidly deteriorating.

Purpose of the Study:

  • To identify prognostic factors for poor outcomes in pediatric dilated cardiomyopathy.
  • To determine risk factors for impending death to guide cardiac transplant decisions.

Main Methods:

  • A cohort of 22 children (median age 5 years) with dilated cardiomyopathy was followed for 40 months.
  • Clinical data and laboratory studies including ECG, Holter, echocardiography, and chest X-ray were analyzed.
  • Comparison of clinical and laboratory findings between survivors and non-survivors was performed.

Main Results:

  • At follow-up, 31.8% improved, 31.8% remained unchanged, and 36% worsened.
  • Mortality was 40.9% (9 out of 22), with survival rates of 72% at 12 months and 59.3% at 60 months.
  • Reduced fractional shortening was the only statistically significant predictor of poor outcome (p < 0.025).

Conclusions:

  • Pediatric dilated cardiomyopathy exhibits variable natural history.
  • Fractional shortening is a critical prognostic indicator in pediatric dilated cardiomyopathy.
  • Identifying high-risk patients is crucial for timely therapeutic interventions like cardiac transplantation.

Related Concept Videos